ArticleHeart rhythm O22026
Leadless pacemaker implantation during pregnancy: Quantitative assessment of fetal radiation exposure.
Article in Heart rhythm O2, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Leadless pacemakers offer an alternative to conventional pacing by eliminating lead- and pocket-related complications. However, their use during pregnancy remains very limited because of concerns related to radiation exposure. We describe the clinical experience of a 17-week pregnant patient who presented with episodes of dizziness, profound weakness, and syncope. Further evaluation revealed second-degree atrioventricular block, Mobitz type II, and transient third-degree atrioventricular block documented by Holter monitoring, indicating the need for permanent pacing. The patient underwent implantation of a Micra AV (Medtronic, USA) leadless pacemaker under fluoroscopic guidance using optimized radiation safety protocols. The estimated fetal absorbed dose was 1.4 mGy, well below reported thresholds for deterministic effects and associated with a very low additional radiation risk compared with background risks of congenital malformations and childhood cancer. The maternal effective dose was 15 mSv. Post-procedure follow-up demonstrated complete symptom resolution, an uncomplicated continuation of pregnancy, and delivery of a healthy infant. This case illustrates the practical feasibility of leadless pacemaker implantation during pregnancy when careful radiation minimization strategies are applied and adds real-world experience to the limited data available for critical pacing indications in pregnant patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.